SWOT Analysis for C4 Therapeutics Inc

Positive Breakout Second Resistance ( LTP > R2)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Positive Breakout (LTP > R2)
Companies with Low Debt
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Highest fall from 52 Week High
Near 52 Week Low
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 2 quarters
Stocks Underperforming their Industry Price Change in the Quarter